Dr. Mark J. Mendolla, MD

Dr. Mendolla practices at Holmes Regional Medical Center in Melbourne, Florida, part of Health First.

Dr. Mendolla's NPI, 1679559199, was assigned on December 16, 2005. Dr. Mendolla graduated from Rutgers New Jersey Medical School in 1989. Dr. Mendolla holds Florida license ME67965.

Dr. Mendolla's primary practice is Holmes Regional Medical Center, at 1350 S Hickory St, Melbourne, FL 32901 in Brevard County. The practice phone is (321) 434-7000.

Dr. Mendolla's primary practice is Holmes Regional Medical Center in Melbourne, Florida, part of Health First. Dr. Mendolla is also affiliated with Viera Hospital. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Mendolla to 3 more hospitals, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mendolla practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mendolla's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mendolla is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Mendolla is licensed in Florida.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, arterial blot clot /embolism, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy and cerebrovascular disease among the conditions Dr. Mendolla treats.

CMS data shows 16,170 Medicare services from Dr. Mendolla across 42 procedure codes in 2024, for 5,891 Medicare patients. Medicare paid $595,857 for them.

CMS counts 5,891 Medicare patients who saw Dr. Mendolla in 2024. The largest group is 75 to 84, with 2,295 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mendolla's median patient age at 74, with 50% women.

In 2024, Dr. Mendolla wrote 8,098 Medicare Part D claims for 1,043 patients. 74% of them were for generic drugs. CMS names the drug for 7,843 of them, across 67 drugs with 11 or more claims each, at $2,326,301 in total drug cost. In 2023, CMS named 7,449 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Mendolla for performance year 2024, reported through an alternative payment model (APM). Dr. Mendolla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 505 general payments to Dr. Mendolla from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,213.

Dmand AI lists 2 awards for Dr. Mendolla, most recently ACC Fellow in 2011.

Dr. Mendolla graduated from Rutgers New Jersey Medical School in 1989. Dr. Mendolla is a member of ACC.

Dr. Mendolla is in network with 11 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.